Uniphar (UPR) Competitors GBX 166 -3.00 (-1.78%) (As of 12/20/2024 04:12 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlines UPR vs. UDG, ONT, CLIN, EMIS, INDV, GNS, VEC, SPI, CTH, and CRWShould you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), Oxford Nanopore Technologies (ONT), Clinigen Group (CLIN), EMIS Group (EMIS), Indivior (INDV), Genus (GNS), Vectura Group (VEC), Spire Healthcare Group (SPI), CareTech (CTH), and Craneware (CRW). These companies are all part of the "medical" sector. Uniphar vs. UDG Healthcare Oxford Nanopore Technologies Clinigen Group EMIS Group Indivior Genus Vectura Group Spire Healthcare Group CareTech Craneware Uniphar (LON:UPR) and UDG Healthcare (LON:UDG) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership, community ranking and earnings. Is UPR or UDG a better dividend stock? Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 1.2%. UDG Healthcare pays an annual dividend of GBX 0.17 per share. Uniphar pays out 1,428.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Do institutionals & insiders believe in UPR or UDG? 45.3% of Uniphar shares are owned by institutional investors. 10.1% of Uniphar shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer UPR or UDG? In the previous week, Uniphar had 1 more articles in the media than UDG Healthcare. MarketBeat recorded 1 mentions for Uniphar and 0 mentions for UDG Healthcare. UDG Healthcare's average media sentiment score of 0.00 beat Uniphar's score of -1.10 indicating that UDG Healthcare is being referred to more favorably in the news media. Company Overall Sentiment Uniphar Negative UDG Healthcare Neutral Do analysts recommend UPR or UDG? Uniphar currently has a consensus target price of GBX 310, suggesting a potential upside of 86.75%. Given Uniphar's stronger consensus rating and higher possible upside, research analysts plainly believe Uniphar is more favorable than UDG Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Uniphar 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00UDG Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is UPR or UDG more profitable? Uniphar has a net margin of 1.69% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.91% beat UDG Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Uniphar1.69% 13.91% 3.76% UDG Healthcare N/A N/A N/A Which has stronger earnings & valuation, UPR or UDG? Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniphar£2.68B0.17£45.17M£0.141,185.71UDG Healthcare£1.25B0.00N/A£25.40N/A Does the MarketBeat Community favor UPR or UDG? UDG Healthcare received 513 more outperform votes than Uniphar when rated by MarketBeat users. However, 100.00% of users gave Uniphar an outperform vote while only 74.68% of users gave UDG Healthcare an outperform vote. CompanyUnderperformOutperformUnipharOutperform Votes6100.00% Underperform VotesNo VotesUDG HealthcareOutperform Votes51974.68% Underperform Votes17625.32% SummaryUniphar beats UDG Healthcare on 13 of the 17 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Uniphar News Delivered to You Automatically Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPR vs. The Competition Export to ExcelMetricUnipharMedical Distribution IndustryMedical SectorLON ExchangeMarket Cap£453.21M£246.19M£5.14B£1.89BDividend Yield0.76%1.32%5.09%5.46%P/E Ratio1,185.7195.4390.131,846.95Price / Sales0.179.211,116.25390,245.05Price / Cash9.979.9743.1028.65Price / Book1.301.304.782.79Net Income£45.17M£45.17M£120.31M£155.66M7 Day Performance-6.21%0.03%-1.92%-2.02%1 Month Performance-7.26%-3.07%13.65%21.50%1 Year Performance-24.20%-8.30%28.34%29.47% Uniphar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPRUniphar1.2246 of 5 starsGBX 166-1.8%GBX 310+86.7%-24.2%£453.21M£2.68B1,185.713,000News CoverageNegative NewsUDGUDG HealthcareN/AGBX 1,079flatN/AN/A£2.72B£1.25B42.489,000ONTOxford Nanopore Technologies1.55 of 5 starsGBX 157.13+2.0%GBX 235.50+49.9%-30.7%£1.48B£167.75M-774.001,281Positive NewsCLINClinigen GroupN/AGBX 925flatN/AN/A£1.23B£565.60M64.691,000EMISEMIS GroupN/AGBX 1,920flatN/AN/A£1.23B£176.86M4,085.111,560INDVIndivior2.5037 of 5 starsGBX 950+4.6%GBX 1,500+57.9%-21.9%£1.22B£1.15B-1,135.001,000Analyst ForecastGNSGenus1.4566 of 5 starsGBX 1,630-0.2%GBX 2,150+31.9%-30.6%£1.07B£668.80M13,616.67480VECVectura GroupN/AGBX 164.80flatN/AN/A£1.01B£190.60M8.209,200SPISpire Healthcare Group2.4682 of 5 starsGBX 228-0.2%GBX 322+41.2%-1.5%£920.71M£1.44B3,278.57420CTHCareTechN/AGBX 750+0.3%N/AN/A£850.02M£495.40M10,714.2911,000CRWCraneware1.4374 of 5 starsGBX 2,300-1.7%GBX 2,700+17.4%+22.9%£812.82M£189.27M9,192.31734 Related Companies and Tools Related Companies UDG Alternatives ONT Alternatives CLIN Alternatives EMIS Alternatives INDV Alternatives GNS Alternatives VEC Alternatives SPI Alternatives CTH Alternatives CRW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:UPR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Uniphar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
